Impact of the DASH4D Diet on Glycemic Biomarkers in Adults with Type 2 Diabetes: Insights from a Randomized Controlled Feeding Trial

Highlight

• The DASH4D diet, adapted specifically for type 2 diabetes, significantly reduced fructosamine, fasting glucose, and HbA1c levels over 5 weeks.
• The controlled feeding randomized trial included 101 adults with type 2 diabetes, predominantly Black and older adults, enhancing the study’s clinical relevance.
• Findings support the DASH4D dietary approach as an effective glycemic management tool in type 2 diabetes, with implications for clinical dietary counseling.

Study Background